Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SM-020 by DermBiont for Dermatosis: Likelihood of Approval
SM-020 is under clinical development by DermBiont and currently in Phase II for Dermatosis. According to GlobalData, Phase II drugs...
SM-020 by DermBiont for Basal Cell Carcinoma (Basal Cell Epithelioma): Likelihood of Approval
SM-020 is under clinical development by DermBiont and currently in Phase II for Basal Cell Carcinoma (Basal Cell Epithelioma). According...
SM-020 by DermBiont for Squamous Cell Carcinoma: Likelihood of Approval
SM-020 is under clinical development by DermBiont and currently in Phase II for Squamous Cell Carcinoma. According to GlobalData, Phase...